The evolution of colorectal cancer genetics-Part 1

From discovery to practice

Andrew T. Schlussel, Ronald A. Gagliano, Susan Seto-Donlon, Faye Eggerding, Timothy Donlon, Jeffrey Berenberg, Henry T. Lynch

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

Colorectal cancer (CRC) is an increasing burden on our society. Identifying those who are at the greatest risk and improving triage for treatment will have the greatest impact on healthcare. CRC is a prime paradigm for cancer genetics: the majority of disease results from stages of progression lending itself to prevention by early detection of the pre-disease (neoplastic) state. Approximately 10% represent well defined hereditary cancer syndromes. Hereditary CRC has the added benefit that many are slow growing and family members are armed with the knowledge of potential risk of associated carcinomas and empowerment to reduce the disease burden. This knowledge provides the indication for early endoscopic and/or surgical intervention for prevention or treatment of an entire family cohort. The molecular basis of CRC allows enhanced characterization of carcinomas, leading to targeted therapies.

Original languageEnglish (US)
Pages (from-to)326-335
Number of pages10
JournalJournal of Gastrointestinal Oncology
Volume5
Issue number5
DOIs
StatePublished - 2014

Fingerprint

Colorectal Neoplasms
Hereditary Neoplastic Syndromes
Carcinoma
Inborn Genetic Diseases
Triage
Early Diagnosis
Delivery of Health Care
Neoplasms
Therapeutics

All Science Journal Classification (ASJC) codes

  • Oncology
  • Gastroenterology

Cite this

Schlussel, A. T., Gagliano, R. A., Seto-Donlon, S., Eggerding, F., Donlon, T., Berenberg, J., & Lynch, H. T. (2014). The evolution of colorectal cancer genetics-Part 1: From discovery to practice. Journal of Gastrointestinal Oncology, 5(5), 326-335. https://doi.org/10.3978/j.issn.2078-6891.2014.069

The evolution of colorectal cancer genetics-Part 1 : From discovery to practice. / Schlussel, Andrew T.; Gagliano, Ronald A.; Seto-Donlon, Susan; Eggerding, Faye; Donlon, Timothy; Berenberg, Jeffrey; Lynch, Henry T.

In: Journal of Gastrointestinal Oncology, Vol. 5, No. 5, 2014, p. 326-335.

Research output: Contribution to journalReview article

Schlussel, AT, Gagliano, RA, Seto-Donlon, S, Eggerding, F, Donlon, T, Berenberg, J & Lynch, HT 2014, 'The evolution of colorectal cancer genetics-Part 1: From discovery to practice', Journal of Gastrointestinal Oncology, vol. 5, no. 5, pp. 326-335. https://doi.org/10.3978/j.issn.2078-6891.2014.069
Schlussel, Andrew T. ; Gagliano, Ronald A. ; Seto-Donlon, Susan ; Eggerding, Faye ; Donlon, Timothy ; Berenberg, Jeffrey ; Lynch, Henry T. / The evolution of colorectal cancer genetics-Part 1 : From discovery to practice. In: Journal of Gastrointestinal Oncology. 2014 ; Vol. 5, No. 5. pp. 326-335.
@article{91995a2a25694ec7a1756ddb016e5f0d,
title = "The evolution of colorectal cancer genetics-Part 1: From discovery to practice",
abstract = "Colorectal cancer (CRC) is an increasing burden on our society. Identifying those who are at the greatest risk and improving triage for treatment will have the greatest impact on healthcare. CRC is a prime paradigm for cancer genetics: the majority of disease results from stages of progression lending itself to prevention by early detection of the pre-disease (neoplastic) state. Approximately 10{\%} represent well defined hereditary cancer syndromes. Hereditary CRC has the added benefit that many are slow growing and family members are armed with the knowledge of potential risk of associated carcinomas and empowerment to reduce the disease burden. This knowledge provides the indication for early endoscopic and/or surgical intervention for prevention or treatment of an entire family cohort. The molecular basis of CRC allows enhanced characterization of carcinomas, leading to targeted therapies.",
author = "Schlussel, {Andrew T.} and Gagliano, {Ronald A.} and Susan Seto-Donlon and Faye Eggerding and Timothy Donlon and Jeffrey Berenberg and Lynch, {Henry T.}",
year = "2014",
doi = "10.3978/j.issn.2078-6891.2014.069",
language = "English (US)",
volume = "5",
pages = "326--335",
journal = "Journal of Gastrointestinal Oncology",
issn = "2078-6891",
publisher = "Pioneer Bioscience Publishing Company (PBPC)",
number = "5",

}

TY - JOUR

T1 - The evolution of colorectal cancer genetics-Part 1

T2 - From discovery to practice

AU - Schlussel, Andrew T.

AU - Gagliano, Ronald A.

AU - Seto-Donlon, Susan

AU - Eggerding, Faye

AU - Donlon, Timothy

AU - Berenberg, Jeffrey

AU - Lynch, Henry T.

PY - 2014

Y1 - 2014

N2 - Colorectal cancer (CRC) is an increasing burden on our society. Identifying those who are at the greatest risk and improving triage for treatment will have the greatest impact on healthcare. CRC is a prime paradigm for cancer genetics: the majority of disease results from stages of progression lending itself to prevention by early detection of the pre-disease (neoplastic) state. Approximately 10% represent well defined hereditary cancer syndromes. Hereditary CRC has the added benefit that many are slow growing and family members are armed with the knowledge of potential risk of associated carcinomas and empowerment to reduce the disease burden. This knowledge provides the indication for early endoscopic and/or surgical intervention for prevention or treatment of an entire family cohort. The molecular basis of CRC allows enhanced characterization of carcinomas, leading to targeted therapies.

AB - Colorectal cancer (CRC) is an increasing burden on our society. Identifying those who are at the greatest risk and improving triage for treatment will have the greatest impact on healthcare. CRC is a prime paradigm for cancer genetics: the majority of disease results from stages of progression lending itself to prevention by early detection of the pre-disease (neoplastic) state. Approximately 10% represent well defined hereditary cancer syndromes. Hereditary CRC has the added benefit that many are slow growing and family members are armed with the knowledge of potential risk of associated carcinomas and empowerment to reduce the disease burden. This knowledge provides the indication for early endoscopic and/or surgical intervention for prevention or treatment of an entire family cohort. The molecular basis of CRC allows enhanced characterization of carcinomas, leading to targeted therapies.

UR - http://www.scopus.com/inward/record.url?scp=84995783181&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995783181&partnerID=8YFLogxK

U2 - 10.3978/j.issn.2078-6891.2014.069

DO - 10.3978/j.issn.2078-6891.2014.069

M3 - Review article

VL - 5

SP - 326

EP - 335

JO - Journal of Gastrointestinal Oncology

JF - Journal of Gastrointestinal Oncology

SN - 2078-6891

IS - 5

ER -